Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Y. Kagawa; H. Satake; T. Kato; K. Oba; H. Yasui; M. Nakamura; T. Watanabe; K. Hirata; K. Muro; Y. Komatsu; T. Yoshino; K. Yamazaki; H. Mishima; M. Kotaka; A. Tsuji; Y. Kakeji; E. Oki; N. Nagata; S. Junichi

doi:10.1093/annonc/mdy431.021

Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results

Y. Kagawa, H. Satake, T. Kato, K. Oba, H. Yasui, M. Nakamura, T. Watanabe, K. Hirata, K. Muro, Y. Komatsu, T. Yoshino, K. Yamazaki, H. Mishima, M. Kotaka, A. Tsuji, Y. Kakeji, E. Oki, N. Nagata, S. Junichi

消化管外科(2)

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

本文言語	英語
ページ（範囲）	ix34-ix35
ジャーナル	Annals of oncology : official journal of the European Society for Medical Oncology
巻	29
DOI	https://doi.org/10.1093/annonc/mdy431.021
出版ステータス	出版済み - 11月 1 2018

!!!All Science Journal Classification (ASJC) codes

血液学
腫瘍学

UN SDG

この成果は、次の持続可能な開発目標に貢献しています

文献へのアクセス

10.1093/annonc/mdy431.021

他のファイルとリンク

引用スタイル

Kagawa, Y., Satake, H., Kato, T., Oba, K., Yasui, H., Nakamura, M., Watanabe, T., Hirata, K., Muro, K., Komatsu, Y., Yoshino, T., Yamazaki, K., Mishima, H., Kotaka, M., Tsuji, A., Kakeji, Y., Oki, E., Nagata, N., & Junichi, S. (2018). Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. Annals of oncology : official journal of the European Society for Medical Oncology, 29, ix34-ix35. https://doi.org/10.1093/annonc/mdy431.021

Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) : Phase Ib results. / Kagawa, Y.; Satake, H.; Kato, T. その他.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.11.2018, p. ix34-ix35.

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Kagawa, Y, Satake, H, Kato, T, Oba, K, Yasui, H, Nakamura, M, Watanabe, T, Hirata, K, Muro, K, Komatsu, Y, Yoshino, T, Yamazaki, K, Mishima, H, Kotaka, M, Tsuji, A, Kakeji, Y, Oki, E, Nagata, N & Junichi, S 2018, 'Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. ix34-ix35. https://doi.org/10.1093/annonc/mdy431.021

Kagawa Y, Satake H, Kato T, Oba K, Yasui H, Nakamura M その他. Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 11月 1;29:ix34-ix35. doi: 10.1093/annonc/mdy431.021

@article{9a3cd62fafee4ce4bfe2d489a79ec2c9,

title = "Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study): Phase Ib results",

author = "Y. Kagawa and H. Satake and T. Kato and K. Oba and H. Yasui and M. Nakamura and T. Watanabe and K. Hirata and K. Muro and Y. Komatsu and T. Yoshino and K. Yamazaki and H. Mishima and M. Kotaka and A. Tsuji and Y. Kakeji and E. Oki and N. Nagata and S. Junichi",

year = "2018",

month = nov,

day = "1",

doi = "10.1093/annonc/mdy431.021",

language = "English",

volume = "29",

pages = "ix34--ix35",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study)

T2 - Phase Ib results

AU - Kagawa, Y.

AU - Satake, H.

AU - Kato, T.

AU - Oba, K.

AU - Yasui, H.

AU - Nakamura, M.

AU - Watanabe, T.

AU - Hirata, K.

AU - Muro, K.

AU - Komatsu, Y.

AU - Yoshino, T.

AU - Yamazaki, K.

AU - Mishima, H.

AU - Kotaka, M.

AU - Tsuji, A.

AU - Kakeji, Y.

AU - Oki, E.

AU - Nagata, N.

AU - Junichi, S.

PY - 2018/11/1

Y1 - 2018/11/1

UR - http://www.scopus.com/inward/record.url?scp=85081616713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081616713&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy431.021

DO - 10.1093/annonc/mdy431.021

M3 - Article

C2 - 32177998

VL - 29

SP - ix34-ix35

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

ER -